Aptose Biosciences (APTO) Misses Q4 EPS by 34c

Aptose Biosciences (NASDAQ: APTO) reported Q4 EPS of ($0.45), $0.34 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Aptose Biosciences (APTO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c